Folgen
Andreas Buser
Andreas Buser
Blood Transfusion Center, Swiss Red Cross, Basel, Switzerland
Bestätigte E-Mail-Adresse bei usb.ch - Startseite
Titel
Zitiert von
Zitiert von
Jahr
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics, F Passamonti, AS Buser, SS Teo, R Tiedt, JR Passweg, ...
New England Journal of Medicine 352 (17), 1779-1790, 2005
46182005
Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors
A Egli, L Infanti, A Dumoulin, A Buser, J Samaridis, C Stebler, R Gosert, ...
The Journal of infectious diseases 199 (6), 837-846, 2009
8412009
Perioperative myocardial injury after noncardiac surgery: incidence, mortality, and characterization
C Puelacher, G Lurati Buse, D Seeberger, L Sazgary, S Marbot, ...
Circulation 137 (12), 1221-1232, 2018
4472018
Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility
C Sur Chowdhury, S Giaglis, UA Walker, A Buser, S Hahn, P Hasler
Arthritis research & therapy 16, 1-14, 2014
3782014
Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
R Kralovics, SS Teo, S Li, A Theocharides, AS Buser, A Tichelli, ...
Blood 108 (4), 1377-1380, 2006
3422006
Physiology of iron metabolism
S Waldvogel-Abramowski, G Waeber, C Gassner, A Buser, BM Frey, ...
Transfusion Medicine and Hemotherapy 41 (3), 213-221, 2014
3322014
Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease
N Cantoni, HH Hirsch, N Khanna, S Gerull, A Buser, C Bucher, J Halter, ...
Biology of blood and marrow transplantation 16 (9), 1309-1314, 2010
2702010
Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2
R Kralovics, SS Teo, AS Buser, M Brutsche, R Tiedt, A Tichelli, ...
Blood 106 (10), 3374-3376, 2005
2632005
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ...
The Lancet Neurology 21 (3), 246-257, 2022
2492022
Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders
R Kralovics, AS Buser, SS Teo, J Coers, A Tichelli, APC van der Maas, ...
Blood 102 (5), 1869-1871, 2003
2012003
Use of myeloperoxidase for risk stratification in acute heart failure
T Reichlin, T Socrates, P Egli, M Potocki, T Breidthardt, N Arenja, ...
Clinical chemistry 56 (6), 944-951, 2010
1732010
Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I
J Boeddinghaus, T Nestelberger, R Twerenbold, K Wildi, P Badertscher, ...
Circulation 135 (17), 1597-1611, 2017
1712017
Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray
RR De Assis, A Jain, R Nakajima, A Jasinskas, J Felgner, JM Obiero, ...
Nature communications 12 (1), 6, 2021
1662021
Effect of definition on incidence and prognosis of type 2 myocardial infarction
T Nestelberger, J Boeddinghaus, P Badertscher, R Twerenbold, K Wildi, ...
Journal of the American College of Cardiology 70 (13), 1558-1568, 2017
1342017
Early diagnosis of myocardial infarction with point-of-care high-sensitivity cardiac troponin I
J Boeddinghaus, T Nestelberger, L Koechlin, D Wussler, P Lopez-Ayala, ...
Journal of the American college of cardiology 75 (10), 1111-1124, 2020
1242020
Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction
J Boeddinghaus, T Nestelberger, R Twerenbold, JT Neumann, B Lindahl, ...
European heart journal 39 (42), 3780-3794, 2018
1142018
Angiogenesis and vascular endothelial growth factor‐/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2‐V617F mutational status
M Medinger, R Skoda, A Gratwohl, A Theocharides, A Buser, D Heim, ...
British journal of haematology 146 (2), 150-157, 2009
1062009
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants
MT Martinez, CH Bucher, G Stussi, D Heim, A Buser, DA Tsakiris, ...
Bone marrow transplantation 36 (11), 993-1000, 2005
1062005
Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction
N Schaub, T Reichlin, C Meune, R Twerenbold, P Haaf, W Hochholzer, ...
Clinical chemistry 58 (1), 246-256, 2012
982012
The association of preoperative anemia and perioperative allogeneic blood transfusion with the risk of surgical site infection
WP Weber, M Zwahlen, S Reck, H Misteli, R Rosenthal, AS Buser, ...
Transfusion 49 (9), 1964-1970, 2009
972009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20